Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02996591
Other study ID # 2016-0499
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date January 2017
Est. completion date May 2017

Study information

Verified date November 2019
Source Hospital for Special Surgery, New York
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine if there is a difference in patient outcomes with general anesthesia versus spinal anesthesia when given in addition to popliteal and adductor canal nerve blocks for foot and ankle surgery. Popliteal and adductor canal nerve blocks are injections of local anesthetic agents near nerves in the back and front of the knee going to the foot and ankle that provide numbness during and after surgery. These peripheral nerve blocks offer good pain control and reduce the need for opioids (opioids are pain medications such as morphine, Dilaudid, and oxycodone). General anesthesia involves the flow of oxygen and anesthesia gas through a tube which, along with additional intravenous medications, causes unconsciousness and unawareness of sensations during surgery. Spinal anesthesia involves an injection of local anesthetic in the lower back, which causes numbness below the waist. In addition to spinal anesthesia, a sedative is typically given intravenously to cause relaxation and sleepiness throughout surgery.

General, spinal, and nerve block anesthesia are all routinely used for surgery at the Hospital for Special Surgery. General or spinal anesthesia is typically used in addition to peripheral nerve blocks during foot and ankle surgery to 1) allow the surgeons to use a thigh tourniquet to reduce bleeding, 2) provide anesthesia earlier, and 3) prevent unwanted movement. However, it is unclear whether general or spinal anesthesia provides better patient outcomes when given with peripheral nerve blocks. Some reports show that on its own, spinal anesthesia has advantages over general anesthesia in terms of side effects such as nausea and pain. However, these advantages may also be gained from combining peripheral nerve blocks with general anesthesia. Spinal anesthesia can be associated with headache and backache, although headache and backache can also happen after operations performed with general anesthesia. A previous study at the Hospital for Special Surgery showed low rates of nausea among patients who received nerve blocks with spinal anesthesia, and no nausea among patients who received a nerve block with general anesthesia. Therefore, the primary aim of this study is to determine if, as a treatment, either general or spinal anesthesia has advantages over the other treatment in terms of readiness for discharge, side effects, pain and patient satisfaction in an ambulatory foot and ankle population.


Recruitment information / eligibility

Status Completed
Enrollment 36
Est. completion date May 2017
Est. primary completion date May 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- 18-75 aged patients

- American Society of Anesthesiologists (ASA) Physical Status classification 1-3

- Elective foot and ankle day surgery procedures, lasting between 1 and 3 hours as per surgeon, performed by 3 co-investigator surgeons.

- Planned for combined popliteal and adductor canal block

- No contraindications for spinal or LMA general anesthesia

Exclusion Criteria:

- Incapable of providing informed consent

- Contraindications for regional or LMA anesthesia (anticoagulation, infection at injection site)

- Anticipated difficult airway

- BMI>40

- Anticipated surgical procedure time less than 1 hour or more than 3 hours

- Hx of severe postoperative nausea and vomiting

- ASA >3

- Peripheral neuropathy affecting the operative extremity

- Pregnant or nursing women

- Chronic opioid use (daily use of opioids one month prior to surgery/ patients requiring chronic pain interventions)

- Prone position

- Obstructive sleep apnea with planned admission overnight to the hospital

- Known allergy/sensitivity to any study medications

- Planned admission after surgery

- Non-English speaking

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
25 mL of 0.25% bupivacaine plus 2 mg preservative-free (PF) dexamethasone / 30 ml for popliteal nerve block

10 mL of 0.25% bupivacaine plus 2 mg preservative-free (PF) dexamethasone / 30 ml for adductor canal nerve block

Drug:
Midazolam, 2-5 mg IV + Glycopyrrolate, 0.1 mg IV + Ketamine, 10-20 mg + propofol as needed

Procedure:
45-60 mg of 1.5% mepivacaine for spinal anesthesia

LMA insertion + titrated propofol infusion + sevoflurane + ketamine 10 mg/hr for general anesthesia


Locations

Country Name City State
United States Hospital for Special Surgery, New York New York New York

Sponsors (1)

Lead Sponsor Collaborator
Hospital for Special Surgery, New York

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time Until Patient is Ready for Discharge From Post-Anesthesia Care Unit (PACU) to Home. Modified Aldrete Scoring System and Marshall and Chung Postanesthesia Discharge Scoring System, measured in time until discharge criteria is met (in minutes) Duration of stay in recovery room after surgery
Secondary Numerical Rating Scale (NRS) Pain Scores at 1 Hour Postop NRS Pain scores at 1 hour after surgery. Rated on a scale of 0 (no pain) to 10 (worst pain imaginable). 1 hour after PACU admission
Secondary Numerical Rating Scale Pain Scores at 2 Hours Postop Numerical rating scale pain score as reported by the patient at 2 hours post-operatively. Rated on a scale of 0 (no pain) to 10 (worst pain imaginable). 2 hours after PACU admission
Secondary Numerical Rating Scale Pain Scores on Postoperative Day (POD) 1 Numerical Rating Scale Pain from 0-10. 0 being no pain at all. 10 being the worst pain imaginable. 24 hours after surgery
Secondary Postoperative Discomfort and Needs (Post-op Pain, Sore Throat, Back Pain, Nausea, Cold, Hunger, Thirst) Leiden Perioperative Care Patient Satisfaction questionnaire (LPPSq) score. Performed at 1 hour postoperatively. To what degree did patients have the following symptoms. Rated 1-5, 1 being not at all. 5 being extremely. 1 hour after surgery
Secondary Postoperative Discomfort and Needs (Post-op Pain, Sore Throat, Back Pain, Nausea, Cold, Hunger, Thirst) Rating the Nausea/Vomiting of patients post-operatively. 2 hours after surgery
Secondary Postoperative Discomfort and Needs (Post-op Pain, Sore Throat, Back Pain, Nausea, Cold, Hunger, Thirst) Leiden Perioperative Care Patient Satisfaction questionnaire (LPPSq). From 1-5. 1 being not at all. 5 being extremely. Postoperative day 1
Secondary Incidence of Post-dural Puncture Headache Postoperative day 1 and if present, monitored until resolution
Secondary Incidence of Transient Neurologic Symptoms Postoperative day 1 and if present, monitored until resolution
Secondary Opioid Consumption Opioid consumption (mg OME) during inpatient stay Duration of stay in recovery room after surgery (average 2 hours)
Secondary Opioid Consumption Through First Postoperative Day. Measured in mg OME Postoperative day 1
Secondary Non-opioid Analgesic Consumption The number of patients who took non-opioid analgesic medication for post-operative pain between hospital discharge and postoperative day 1. Hospital discharge to postoperative day 1
Secondary Opioid-Related Symptom Distress Scale (ORSDS) Score Opioid-related symptom distress scale. The ORSDS measures patient opioid-related symptoms on a 4-point scale that evaluates 3 symptom distress dimension (severity, frequency, and bothersomeness) for 12 opioid-related symptoms. Scores range from 0-4, and the mean of the 12 answers is the ORSDS score. Higher values indicate worse opioid-related symptoms. 2 hours after surgery
Secondary Cognitive Recovery Postoperative Quality Recovery Scale Cognitive Domain questionnaire. Asked at 1 hour post-operatively. Either yes (return to pre-operative cognitive function levels) or no (not yet returned to pre-operative function levels) 1 hour after surgery
Secondary Incidence of Urinary Catheterization Duration of stay in recovery room after surgery (average 2 hours)
Secondary Anesthesia-related Postoperative Complications Measuring any anesthesia-related post-op complications that occured (yes or no) Surgery start to postoperative day 1
Secondary Assessment of Patient Blinding to Group Assignment Patients will be asked whether they believe they were in the general anesthesia or spinal anesthesia group. These responses are then validated using the Bang Blinding Index, which either confirms or refutes the validity of the blinding. The scale runs from -1 to 1, with a score of 0 indicating complete blinding, -1 indicating opposite guessing of groups, and 1 indicating a complete lack of blinding. Postoperative day 1
Secondary Patient Satisfaction Yes/no if patients would request the same anesthetic that they received POD1
Secondary Cognitive Recovery at 2 Hours Post-operative Postoperative Quality Recovery Scale Cognitive Domain questionnaire. Asked at 2 hour post-operatively. Either yes (return to pre-operative cognitive function levels) or no (not yet returned to pre-operative function levels) 2 hours after PACU admission
Secondary Cognitive Recovery on POD1 Postoperative Quality Recovery Scale Cognitive Domain questionnaire. Asked on postoperative day 1. Either yes (return to pre-operative cognitive function levels) or no (not yet returned to pre-operative function levels) Postoperative day 1
Secondary Nausea Intensity Nausea intensity ranked on NRS score following PACU admission to 2 hours after discharge. Scored from 0-10. 0 Being no nausea, 10 being worst nausea imaginable. 2 hours after PACU admission
Secondary Back Pain on POD1 Back pain (yes/no) on POD1 Postoperative day 1
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05559255 - Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI N/A
Completed NCT04748367 - Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care N/A
Terminated NCT04356352 - Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain Phase 2/Phase 3
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04466111 - Observational, Post Market Study in Treating Chronic Upper Extremity Limb Pain
Recruiting NCT05868122 - A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy Phase 3
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Completed NCT03273114 - Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain N/A
Enrolling by invitation NCT06087432 - Is PNF Application Effective on Temporomandibular Dysfunction N/A
Completed NCT05508594 - Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001 Phase 2/Phase 3
Recruiting NCT03646955 - Partial Breast Versus no Irradiation for Women With Early Breast Cancer N/A
Active, not recruiting NCT03472300 - Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
Completed NCT03678168 - A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries N/A
Completed NCT03931772 - Online Automated Self-Hypnosis Program N/A
Completed NCT03286543 - Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System N/A
Completed NCT02913027 - Can We Improve the Comfort of Pelvic Exams? N/A
Terminated NCT02181387 - Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor? Phase 4
Recruiting NCT06032559 - Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment Phase 3
Active, not recruiting NCT03613155 - Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care